Literature DB >> 6327924

Increased incidence of acute nonlymphocytic leukemia following therapy in patients with small cell carcinoma of the lung.

L Y Chak, B I Sikic, M A Tucker, R C Horns, R S Cox.   

Abstract

A group of 158 patients with small cell carcinoma of the lung were followed for 174.5 person-years of observation to determine the risk of acute leukemia. Three cases of acute nonlymphocytic leukemia were observed at 2.3, 2.7, and 3.0 years. The relative risk of developing leukemia was 316 (95% confidence limit, 76-818) and the actuarial risk was 25% +/- 13% at 3.1 years. The relative risk for leukemia was significantly increased in these patients (p less than 0.0001).

Entities:  

Mesh:

Year:  1984        PMID: 6327924     DOI: 10.1200/JCO.1984.2.5.385

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  6 in total

1.  Therapy-related acute nonlymphocytic leukemia: clinical aspects.

Authors:  J Pedersen-Bjergaard
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

2.  Risk of leukaemia associated with cancer chemotherapy.

Authors:  J M Whitehouse
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-26

3.  Cytogenetic effect of carboplatin on human lymphocytes.

Authors:  T Shinkai; N Saijo; K Eguchi; Y Sasaki; T Tamura; M Sakurai; J Suga; H Nakano; K Nakagawa; W S Hong
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  Multiple primary cancers in Connecticut, 1935-82.

Authors:  J D Boice; R E Curtis; R A Kleinerman; J T Flannery; J F Fraumeni
Journal:  Yale J Biol Med       Date:  1986 Sep-Oct

5.  Serial measurement of sister chromatid exchanges in the peripheral lymphocytes of patients with lung cancer receiving chemotherapy in relation to bone marrow toxicity.

Authors:  T Shinkai; N Saijo; K Eguchi; Y Sasaki; T Tamura; Y Fujiwara; A Kojima; K Nakagawa; K Minato; T Nakajima
Journal:  Jpn J Cancer Res       Date:  1989-08

6.  Clinicopathological features, risk and survival in lung cancer survivors with therapy-related acute myeloid leukaemia.

Authors:  Huabin Wang; Yin Yin; Ru Wang; Junbin Huang; Hongman Xue; Yucai Cheng; Lidan Zhang; Chun Chen
Journal:  BMC Cancer       Date:  2020-11-10       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.